AGTR1 and malignant hypertension: Abnormal activation of AT1 receptor leads to a number of pathophysiologies including cardiovascular remodeling and hypertrophy, vascular inflammation and atherosclerosis, endothelial dysfunction, oxidative stress, extra cellular matrix deposition, insulin resistance, angiogenesis and cancer, autoantibodies and malignant hypertension [1].